User login
- /content/entospletinib-falls-short-relapsed/refractory-dlbcl
- /hematologynews/article/177043/aggressive-lymphomas/entospletinib-falls-short-relapsed/refractory
- /oncologypractice/article/177043/aggressive-lymphomas/entospletinib-falls-short-relapsed/refractory
- /hematologynews/nhlhub/article/177043/aggressive-lymphomas/entospletinib-falls-short-relapsed
- /hematology-oncology/article/177043/aggressive-lymphomas/entospletinib-falls-short-relapsed
- /b-cell-lymphoma-icymi/article/177043/aggressive-lymphomas/entospletinib-falls-short-relapsed